Tumor-induced osteomalacia

Panminerva Med. 2023 Dec 21. doi: 10.23736/S0031-0808.23.05047-4. Online ahead of print.ABSTRACTTumor-induced osteomalacia is one of paraneoplastic syndromes characterized by hypophosphatemia caused by excessive actions of fibroblast growth factor 23 (FGF23). Since the cloning of FGF23 about 20 years ago, more widespread awareness of this disease has been achieved. However, there still remain several difficulties in the management of patients with this disease. In this review, these clinical problems are discussed together with the physiological and pathophysiological functions of FGF23. Personal proposals in the management of patients with suspected patients with tumor-induced osteomalacia are also presented.PMID:38127062 | DOI:10.23736/S0031-0808.23.05047-4
Source: Panminerva Medica - Category: General Medicine Authors: Source Type: research